None listed
Conditions
Interventions
Intervention1: Tacrolimus Eluting Carbostent: Stent is drug Eluting stent.No additional drug
Control Intervention1: not applicable: no controls
Sponsors
Dr. Maddury Jyotsna, Associate Professor of Cardiology, Department of Cardiology, NIMS, Panjagutta, Hyderabad, A.P., India-500 082
Worldmed Equipments Pvt Ltd, Door NO
35/17,unit no :102, Frist Floor, Primier Residency,Langford road,Bangalore-560 025,INDIA
Eligibility
Inclusion criteria
Inclusion criteria: Patient with acute coronary syndrome (acute myocardial infarction or recent myocardial infarction with post MI angina or unstable angina - with in 15 days of event) admitted to hospital who are under going Percutaneous intervention are included.
Exclusion criteria
Exclusion criteria: 1. Patients with thrombocytopenia or any other hematological abnormality. 2. Patient in cardiogenic shock. 3. Patients who refuses for tacrolimus eluting Carbostent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MACE ( major cardivascular events) Timepoint: 7 days, one month , 6 months and one year | — |
Secondary
| Measure | Time frame |
|---|---|
| Quqntitative Coronary Angiogram wise luminal lossTimepoint: one year | — |
Countries
India
Contacts
Public ContactMr.Narendra Kumar RNV
Nizam's institute of medical sciences(NIMS)
Outcome results
None listed